Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican and US Blood Donors - CTS
NCT ID: NCT01702272
Last Updated: 2014-09-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
150000 participants
OBSERVATIONAL
2013-01-31
2014-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican Blood Donors - American Red Cross
NCT01656174
Dengue - Sample Collection Study Pakistan
NCT07203183
A Normal Donor Sample Collection Study in Healthy Adults
NCT01318863
A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA
NCT00520273
Clinical Protocol SeCore, uTYPE and 3500 Dx System
NCT01285427
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dengue Virus
Procleix Dengue Virus Assay
in vitro diagnostic assay
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Procleix Dengue Virus Assay
in vitro diagnostic assay
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Donor and/or legally authorized representative must be willing to undergo the site's routine informed consent process prior to study participation.
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gen-Probe, Incorporated
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jennifer Reid, PhD
Role: STUDY_DIRECTOR
Gen-Probe, Incorporated
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Creative Testing Solutions - Tampa
St. Petersburg, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DENVTS-US12-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.